179 related articles for article (PubMed ID: 38129361)
1. Curcumin inhibits the invasion and migration of pancreatic cancer cells by upregulating TFPI-2 to regulate ERK- and JNK-mediated epithelial-mesenchymal transition.
Zhai LL; Li WB; Chen LJ; Wang W; Ju TF; Yin DL
Eur J Nutr; 2024 Mar; 63(2):639-651. PubMed ID: 38129361
[TBL] [Abstract][Full Text] [Related]
2. Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis.
Li W; Sun L; Lei J; Wu Z; Ma Q; Wang Z
Oncol Rep; 2020 Jul; 44(1):382-392. PubMed ID: 32377752
[TBL] [Abstract][Full Text] [Related]
3. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway.
Cao L; Liu J; Zhang L; Xiao X; Li W
Oncol Rep; 2016 Oct; 36(4):2245-51. PubMed ID: 27572503
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA XLOC_000647 suppresses progression of pancreatic cancer and decreases epithelial-mesenchymal transition-induced cell invasion by down-regulating NLRP3.
Hu H; Wang Y; Ding X; He Y; Lu Z; Wu P; Tian L; Yuan H; Liu D; Shi G; Xia T; Yin J; Cai B; Miao Y; Jiang K
Mol Cancer; 2018 Jan; 17(1):18. PubMed ID: 29386037
[TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
7. Effects of microRNA-183 on epithelial-mesenchymal transition, proliferation, migration, invasion and apoptosis in human pancreatic cancer SW1900 cells by targeting MTA1.
Lin X; Zheng L; Song H; Xiao J; Pan B; Chen H; Jin X; Yu H
Exp Mol Pathol; 2017 Jun; 102(3):522-532. PubMed ID: 28506766
[TBL] [Abstract][Full Text] [Related]
8. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
Sun XD; Liu XE; Huang DS
Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
[TBL] [Abstract][Full Text] [Related]
9. Curcumin suppresses epithelial-to-mesenchymal transition of peritoneal mesothelial cells (HMrSV5) through regulation of transforming growth factor-activated kinase 1 (TAK1).
Zhao JL; Guo MZ; Zhu JJ; Zhang T; Min DY
Cell Mol Biol Lett; 2019; 24():32. PubMed ID: 31143210
[TBL] [Abstract][Full Text] [Related]
10. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
[TBL] [Abstract][Full Text] [Related]
11. Curcumin Inhibits the Migration and Invasion of Non-Small-Cell Lung Cancer Cells Through Radiation-Induced Suppression of Epithelial-Mesenchymal Transition and Soluble E-Cadherin Expression.
Deng X; Chen C; Wu F; Qiu L; Ke Q; Sun R; Duan Q; Luo M; Luo Z
Technol Cancer Res Treat; 2020; 19():1533033820947485. PubMed ID: 33124505
[TBL] [Abstract][Full Text] [Related]
12. AREG mediates the epithelial‑mesenchymal transition in pancreatic cancer cells via the EGFR/ERK/NF‑κB signalling pathway.
Wang L; Wang L; Zhang H; Lu J; Zhang Z; Wu H; Liang Z
Oncol Rep; 2020 May; 43(5):1558-1568. PubMed ID: 32323797
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
14. m
Wang W; He Y; Zhai LL; Chen LJ; Yao LC; Wu L; Tang ZG; Ning JZ
Epigenetics; 2022 Dec; 17(12):1738-1752. PubMed ID: 35404184
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway by targeting CUL4B in pancreatic cancer cells.
Zhang JQ; Chen S; Gu JN; Zhu Y; Zhan Q; Cheng DF; Chen H; Deng XX; Shen BY; Peng CH
J Cell Biochem; 2018 Jan; 119(1):1027-1040. PubMed ID: 28685847
[TBL] [Abstract][Full Text] [Related]
16. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
[TBL] [Abstract][Full Text] [Related]
17. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
[TBL] [Abstract][Full Text] [Related]
18. LncRNA XIST promotes pancreatic cancer migration, invasion and EMT by sponging miR-429 to modulate ZEB1 expression.
Shen J; Hong L; Yu D; Cao T; Zhou Z; He S
Int J Biochem Cell Biol; 2019 Aug; 113():17-26. PubMed ID: 31163263
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia promotes pancreatic cancer cell migration, invasion, and epithelial-mesenchymal transition via modulating the FOXO3a/DUSP6/ERK axis.
Zhao H; Chen W; Zhu Y; Lou J
J Gastrointest Oncol; 2021 Aug; 12(4):1691-1703. PubMed ID: 34532120
[TBL] [Abstract][Full Text] [Related]
20. SPOCK1 promotes metastasis in pancreatic cancer via NF-κB-dependent epithelial-mesenchymal transition by interacting with IκB-α.
Cui X; Wang Y; Lan W; Wang S; Cui Y; Zhang X; Lin Z; Piao J
Cell Oncol (Dordr); 2022 Feb; 45(1):69-84. PubMed ID: 34855159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]